- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02018471
Psychological Counselling in Diagnostic Screening
Management of Anxiety Related to Diagnostic Screenings: an Exploratory Pilot Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The Psychoeducative Training was organized in 6 weekly meetings lasting two hours. Each group was composed of 6 participants. The Training follows the cognitive-behavioural model. In the first part of every meeting, theoretical aspects about stress and anxiety were explained, while in the second part some relaxation techniques were taught. During relaxation, we used a selected music that was also going to be used during the diagnostic tests. Since the first meeting, patients experienced these relaxing techniques in order to learn them. In order to support the adaptability, at the end of every meeting the participants received some homework. They had to take notes on how many times they repeated the relaxation exercises and on the anxiety level before and after the training.
For the study, 43 people were recruited. Anxiety was measured with Beck Anxiety Inventory (BAI); it values the seriousness of the physiological behaviour connected with anxiety. This test an "anxiety gauge", which allows us to obtain numerical data on emotional changes. The test is composed of 4 interpretative levels: serious, moderate, small and minimal anxiety.
The coping style was measured with Coping Orientation to Problems Experienced-New Italian Version (COPE-NIV); this test evaluates the way in which people resolve and face traumatic or usual stressful situations.
The research project was approved by the Ethics Committee of Veneto Institute of Oncology.
Every patient signed a written informed consent to process the data for research purposes and to publish it.
Forty-three patients who had to undergo one or more diagnostic tests (PET, TAC, fMRI, Mammography, Endoscopy, Colonoscopy) took part in the study. The average age was 52.4 and 61.5% were married.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- age: 25 to 65 years cancer patients who must undergo diagnostic tests: TAC, PET, fMRI, Mammography, Endoscopy and Colonoscopy.
- an anxiety level greater than 5 (in a scale from 0=very calm to 10=very anxious; using a self-reporting instrument created ad hoc)
- signed informed consent
Exclusion Criteria:
- healthy people
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Pilot group
Forty-three patients who had to undergo one or more diagnostic tests (PET, TAC, fMRI, Mammography, Endoscopy, Colonoscopy) took part in the study.
Most of the 43 patients had to undergo only one diagnostic test, and only 6 patients had more than one.
They have attended a psychoeducative training.
|
The Psychological education was inspired by the technique, Systematic Desensitization (SD), a therapeutic procedure that seeks to eliminate fear and avoidance behaviour
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Proportion of patients considered drop-outs
Délai: 6 weeks after recruitment (end of treatment)
|
The proportion of patients considered drop-outs.
A patient is considered a drop-out if he/she does not attend at least 2 out of 6 programmed meetings.
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
median BAI score after intervention
Délai: 6 weeks after recruitment (end of treatment)
|
This is an efficacy outcome
|
6 weeks after recruitment (end of treatment)
|
|
median COPE score - Social support score after intervention
Délai: 6 weeks after recruitment (end of treatment)
|
This is an efficacy outcome
|
6 weeks after recruitment (end of treatment)
|
|
median COPE score - Avoidance strategies score after intervention
Délai: 6 weeks after recruitment (end of treatment)
|
This is an efficacy outcome
|
6 weeks after recruitment (end of treatment)
|
|
median COPE score - Positive attitude score after intervention
Délai: 6 weeks after recruitment (end of treatment)
|
This is an efficacy outcome
|
6 weeks after recruitment (end of treatment)
|
|
median COPE score - Problem acceptance score after intervention
Délai: 6 weeks after recruitment (end of treatment)
|
This is an efficacy outcome
|
6 weeks after recruitment (end of treatment)
|
|
recruitment time (process)
Délai: 6 weeks after recruitment (end of treatment)
|
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
|
mean number of recruited patients per week (process)
Délai: 6 weeks after recruitment (end of treatment)
|
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
|
refusal rate among eligible patients (process)
Délai: 6 weeks after recruitment (end of treatment)
|
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
|
rate of patients who obviously meet and do not meet the eligibility requirements (process)
Délai: 6 weeks after recruitment (end of treatment)
|
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
|
number of questionnaires correctly filled out (process)
Délai: 6 weeks after recruitment (end of treatment)
|
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
|
phone lines overloaded or waiting room overcrowded by study participants (management)
Délai: 6 weeks after recruitment (end of treatment)
|
This is a feasibility outcome
|
6 weeks after recruitment (end of treatment)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Malihe Shams, Istituto Oncologico Veneto IRCCS
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- IOV-2012 ANXIETY
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .